Name | N-[4-[2-(6-cyano-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]cyclohexyl]quinoline-4-carboxamide |
---|---|
Synonyms |
N-{trans-4-[2-(6-Cyano-3,4-dihydro-2(1H)-isoquinolinyl)ethyl]cyclohexyl}-4-quinolinecarboxamide
cc-478 4-Quinolinecarboxamide, N-[trans-4-[2-(6-cyano-3,4-dihydro-2(1H)-isoquinolinyl)ethyl]cyclohexyl]- N-{trans-4-[2-(6-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl]cyclohexyl}quinoline-4-carboxamide SB-277011 |
Description | SB-277011 is a potent and delective dopamine D3 receptor antagonist (pKi values are 8.0, 6.0, 5.0 and <5.2 for D3, D2, 5-HT1D and 5-HT1B respectively); brain penetrant.IC50 value: 8.0 (pKi)Target: D3 receptor |
---|---|
Related Catalog | |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 679.3±55.0 °C at 760 mmHg |
Molecular Formula | C28H30N4O |
Molecular Weight | 438.564 |
Flash Point | 364.6±31.5 °C |
Exact Mass | 438.241974 |
PSA | 69.02000 |
LogP | 4.26 |
Vapour Pressure | 0.0±2.1 mmHg at 25°C |
Index of Refraction | 1.656 |
Storage condition | 2-8℃ |